Compass Pathways Plc’s shares plummeted after its psychedelic drug to treat a form of depression disappointed investors in a ...

Compass Pathways’ depression drug trial meets goals but falls short of investor hopes, triggering a sharp share selloff.

A new study reveals that the same clinical signs of depression may stem from different brain profiles, highlighting both ...

Lower diversity in the oral microbiome was linked to higher depressive symptoms in a large U.S. sample, with especially ...

A novel study aimed at disentangling the neurological underpinnings of depression shows that multiple brain profiles may ...

Postnatal depression is common in new fathers, who often endure stereotypes they need to be strong and stoic — but help is at ...

Discover 8 surprising reasons why depression can worsen even while taking medication, including lifestyle factors and medical ...

Researchers followed thousands of pre-teens for three years, generating unique insights into how social media is shaping kids ...

Adults with treatment-resistant depression who received IV ketamine showed improvement in sadness-related symptoms ...

Are memory lapses a result of normal aging or symptoms of something more serious? Then, a closer look at a new device ...

New research, presented today at the European Academy of Neurology (EAN) Congress 2025, has uncovered a powerful link between ...